GlassScriptPhysician profile
Suresh Prasad
NPI 1053419572
$89,813.87
in general payments reported to CMS, 2019-2025
18 companies · $49.06 in 2025
The $49.06 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $11K · 2021: $13K · 2022: $19K · 2023: $22K · 2024: $88.67 · 2025: $49.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $1,445 · Food and Beverage: $710 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,575.00 |
| Travel and Lodging | $1,444.66 |
| Food and Beverage | $709.66 |
| Education | $144.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $67,315.00 | 2019-2022 | |
| Lilly USA, LLC | $21,603.13 | 2023 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $272.52 | 2021-2024 | Veozah |
| Harmony Biosciences LLC | $176.91 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $72.61 | 2019 | |
| Glaxosmithkline, LLC. | $70.59 | 2019-2022 | |
| Abbott Laboratories | $64.64 | 2021-2025 | Proclaim |
| Xeris Pharmaceuticals, INC. | $47.15 | 2024-2025 | Gvoke Hypopen |
| Genentech USA, INC. | $38.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $21.17 | 2021 | |
| Jazz Pharmaceuticals INC. | $18.61 | 2022 | |
| Allergan, INC. | $18.12 | 2019 | |
| Insulet Corporation | $17.73 | 2022 | |
| Tactile Systems Technology INC | $16.09 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.96 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.79 | 2023 | |
| Medtronic, INC. | $15.01 | 2023 | Minimed 780g |
| Novartis Pharmaceuticals Corporation | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Prasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.